Condition
Gonorrhea Male
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05294588Phase 2CompletedPrimary
Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
NCT06468462Phase 4RecruitingPrimary
Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM
NCT04553211Not ApplicableCompleted
Expedited Partner Therapy and the HIV Prevention Cascade
NCT03741725Not ApplicableCompletedPrimary
Pay-it-forward RCT for Gonorrhea and Chlamydia Testing
Showing all 4 trials